Reconciling the Potentially Irreconcilable? Genotypic and Phenotypic Amoxicillin-Clavulanate Resistance in Escherichia coli

Evaluation of empiric beta-lactam susceptibility prediction among Enterobacteriaceae by molecular beta-lactamase gene testing

(2019) Kyle Spafford et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Validating the NCBI AMRFinder Tool and Resistance Gene Database Using Antimicrobial Resistance Genotype-Phenotype Correlations in a Collection of NARMS Isolates

(2019) Michael Feldgarden et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Effect of Piperacillin-Tazobactam vs Meropenem on 30-Day Mortality for Patients With E coli or Klebsiella pneumoniae Bloodstream Infection and Ceftriaxone Resistance

(2018) Patrick N. A. Harris et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Trends over time in Escherichia coli bloodstream infections, urinary tract infections, and antibiotic susceptibilities in Oxfordshire, UK, 1998–2016: a study of electronic health records

(2018) Karina-Doris Vihta et al.   LANCET INFECTIOUS DISEASES

Antimicrobial use in European acute care hospitals: results from the second point prevalence survey (PPS) of healthcare-associated infections and antimicrobial use, 2016 to 2017

(2018) Diamantis Plachouras et al.   Eurosurveillance

Genome-based prediction of bacterial antibiotic resistance

(2018) Michelle Su et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Systematic longitudinal survey of invasive Escherichia coli in England demonstrates a stable population structure only transiently disturbed by the emergence of ST131

(2017) Teemu Kallonen et al.   GENOME RESEARCH

Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli

(2017) N. Stoesser et al.   Scientific Reports

CTX-M-190, a Novel β-Lactamase Resistant to Tazobactam and Sulbactam, Identified in an Escherichia coli Clinical Isolate

(2016) Zhen Shen et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Establishing the validity of different susceptibility testing methods to evaluate the in vitro activity of amoxicillin-clavulanate against Escherichia coli

(2016) Díez-Aguilar María et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE

A resurgence of β-lactamase inhibitor combinations effective against multidrug-resistant Gram-negative pathogens

(2015) Karen Bush   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Performance of EUCAST and CLSI approaches for co-amoxiclav susceptibility testing conditions for clinical categorization of a collection ofEscherichia coliisolates with characterized resistance phenotypes

(2015) María Díez-Aguilar et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

WGS accurately predicts antimicrobial resistance inEscherichia coli

(2015) Gregory H. Tyson et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data

(2013) N. Stoesser et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Spanish Multicenter Study of the Epidemiology and Mechanisms of Amoxicillin-Clavulanate Resistance in Escherichia coli

(2012) Adriana Ortega et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing

(2012) E. Zankari et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

An efficient record linkage scheme using graphical analysis for identifier error detection

(2011) John M Finney et al.   BMC Medical Informatics and Decision Making

Detection of AmpC Beta-Lactamase in Escherichia coli: Comparison of Three Phenotypic Confirmation Assays and Genetic Analysis

(2011) S. Peter-Getzlaff et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Three Decades of  -Lactamase Inhibitors

(2010) S. M. Drawz et al.   CLINICAL MICROBIOLOGY REVIEWS

Velvet: Algorithms for de novo short read assembly using de Bruijn graphs

(2008) D. R. Zerbino et al.   GENOME RESEARCH